W. Luo

发表

Actively Transported Levodopa Prodrug XP21279: A Study in Patients With Parkinson Disease Who Experience Motor Fluctuations

P. Lewitt, K. Zomorodi, F. Huff, 2012, Clinical neuropharmacology.

Properties Compared to R-Baclofen.

M. Gallop, J. Sukbuntherng, K. Koller, 2009 .

Evaluation of gabapentin enacarbil on cardiac repolarization: a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.

K. Zomorodi, Dan Chen, R. Lal, 2012, Clinical therapeutics.

Reproducibility of the measurement of sweet taste preferences

W. Herman, K. Asao, W. Luo, 2012, Appetite.

Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.

J. Sukbuntherng, Dan Chen, R. Lal, 2012, Clinical therapeutics.

Alternative Algorithms for Human Immunodeficiency Virus Infection Diagnosis Using Tests That Are Licensed in the United States

M. Kalish, C. Ou, T. Spira, 2008, Journal of Clinical Microbiology.

Clinical Pharmacokinetics of XP13512, a Novel Transported Prodrug of Gabapentin

W. Luo, K. Cundy, D. Canafax, 2008, Journal of clinical pharmacology.

Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.

J. Sukbuntherng, Dan Chen, R. Lal, 2009, Clinical therapeutics.

Arbaclofen Placarbil, a Novel R-Baclofen Prodrug: Improved Absorption, Distribution, Metabolism, and Elimination Properties Compared with R-Baclofen

M. Gallop, J. Sukbuntherng, K. Koller, 2009, Journal of Pharmacology and Experimental Therapeutics.

A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study to Assess the Pharmacokinetics, Efficacy, and Safety of Gabapentin Enacarbil in Subjects With Restless Legs Syndrome

K. Zomorodi, A. Ellenbogen, Dan Chen, 2012, Clinical neuropharmacology.

XP13512 [(±)-1-([(α-Isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane Acetic Acid], A Novel Gabapentin Prodrug: II. Improved Oral Bioavailability, Dose Proportionality, and Colonic Absorption Compared with Gabapentin in Rats and Monkeys

R. Barrett, M. Gallop, W. Luo, 2004, Journal of Pharmacology and Experimental Therapeutics.

aminomethyl )-1-cyclohexane Acetic Acid ] , A Novel Gabapentin Prodrug : II . Improved Oral Bioavailability , Dose Proportionality , and Colonic Absorption Compared with Gabapentin in Rats and Monkeys

R. Barrett, M. Gallop, W. Luo, 2004 .

Population Pharmacokinetics and Pharmacodynamics of Gabapentin After Administration of Gabapentin Enacarbil

J. Sukbuntherng, R. Lal, W. Luo, 2013, Journal of clinical pharmacology.

Arbaclofen Placarbil Decreases Postprandial Reflux in Patients With Gastroesophageal Reflux Disease

A. Hila, D. Castell, A. Agrawal, 2010, The American Journal of Gastroenterology.

Clinical Evaluation of Xp19986 as a Potential Treatment for GERD: 25

J. Sukbuntherng, F. Huff, R. Lal, 2008 .

Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine.

J. Sukbuntherng, R. Lal, W. Luo, 2010, British journal of clinical pharmacology.

The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbil.

J. Sukbuntherng, F. Huff, R. Lal, 2010, International journal of clinical pharmacology and therapeutics.

The regulatory framework for preventing cross-contamination of pharmaceutical products: History and considerations for the future.

Reena Sandhu, E. V. Sargent, Edward V Sargent, 2016, Regulatory toxicology and pharmacology : RTP.